Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Role of the Inflammasome in Liver Disease
Marcelle de Carvalho Ribeiro, Gyöngyi Szabó
Annual Review of Pathology Mechanisms of Disease (2021) Vol. 17, Iss. 1, pp. 345-365
Open Access | Times Cited: 176

Showing 1-25 of 176 citing articles:

Association of Inflammatory Cytokines With Non-Alcoholic Fatty Liver Disease
Yamei Duan, Xiongfeng Pan, Jiayou Luo, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 212
STING mediates hepatocyte pyroptosis in liver fibrosis by Epigenetically activating the NLRP3 inflammasome
Yang Xiao, Chong Zhao, Yang Tai, et al.
Redox Biology (2023) Vol. 62, pp. 102691-102691
Open Access | Times Cited: 62
Caspase-11 promotes high-fat diet-induced NAFLD by increasing glycolysis, OXPHOS, and pyroptosis in macrophages
Charles Drummer, Fatma Saaoud, Nirag Jhala, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 45
The E3 ubiquitin ligase MARCH2 protects against myocardial ischemia-reperfusion injury through inhibiting pyroptosis via negative regulation of PGAM5/MAVS/NLRP3 axis
Shuolin Liu, Yaguang Bi, Tianting Han, et al.
Cell Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 26
cGAS-STING, inflammasomes and pyroptosis: an overview of crosstalk mechanism of activation and regulation
Jingwen Liu, Jing Zhou, Yuling Luan, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 23
The gasdermin family: emerging therapeutic targets in diseases
Cheng‐long Zhu, Sheng Xu, Ruoyu Jiang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 19
SLC7A11-ROS/αKG-AMPK axis regulates liver inflammation through mitophagy and impairs liver fibrosis and NASH progression
Tingting Lv, Xiude Fan, Chang He, et al.
Redox Biology (2024) Vol. 72, pp. 103159-103159
Open Access | Times Cited: 14
Ferroptosis, necroptosis, and pyroptosis in the occurrence and development of ovarian cancer
Chunmei Zhang, Ning Liu
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 53
The Role of the NLRP3 Inflammasome and Programmed Cell Death in Acute Liver Injury
Chaoqun Yu, Peng Chen, Longyu Miao, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3067-3067
Open Access | Times Cited: 37
GAS5 protects against nonalcoholic fatty liver disease via miR-28a-5p/MARCH7/NLRP3 axis-mediated pyroptosis
Tianxing Chen, Meng Yao, Zhihang Zhou, et al.
Cell Death and Differentiation (2023) Vol. 30, Iss. 7, pp. 1829-1848
Closed Access | Times Cited: 33
The Importance of Antioxidant Activity for the Health-Promoting Effect of Lycopene
Anna Kulawik, Judyta Cielecka‐Piontek, Przemysław Zalewski
Nutrients (2023) Vol. 15, Iss. 17, pp. 3821-3821
Open Access | Times Cited: 28
Activation of Kupffer cells in NAFLD and NASH: mechanisms and therapeutic interventions
Gao-Xin Xu, Wei Song, Chao Yu, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 27
Dimethyl fumarate inhibits necroptosis and alleviates systemic inflammatory response syndrome by blocking the RIPK1-RIPK3-MLKL axis
Fuli Shi, Li-sha Yuan, Tak-sui Wong, et al.
Pharmacological Research (2023) Vol. 189, pp. 106697-106697
Open Access | Times Cited: 23
Lycopene prevents non-alcoholic fatty liver disease through regulating hepatic NF-κB/NLRP3 inflammasome pathway and intestinal microbiota in mice fed with high-fat and high-fructose diet
Xiang Gao, Xia Zhao, Min Liu, et al.
Frontiers in Nutrition (2023) Vol. 10
Open Access | Times Cited: 22
Ginsenoside Rg1 attenuates lipopolysaccharide-induced chronic liver damage by activating Nrf2 signaling and inhibiting inflammasomes in hepatic cells
Huimin Zhou, Yan Liu, Yong Su, et al.
Journal of Ethnopharmacology (2024) Vol. 324, pp. 117794-117794
Closed Access | Times Cited: 11
Hepatic danger signaling triggers TREM2 + macrophage induction and drives steatohepatitis via MS4A7-dependent inflammasome activation
Linkang Zhou, Xiaoxue Qiu, Ziyi Meng, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 738
Closed Access | Times Cited: 11
Silent information regulator sirtuin 1 ameliorates acute liver failure via the p53/glutathione peroxidase 4/gasdermin D axis
Xing-Nian Zhou, Quan Zhang, Hong Peng, et al.
World Journal of Gastroenterology (2024) Vol. 30, Iss. 11, pp. 1588-1608
Open Access | Times Cited: 9
PI3K/AKT signaling pathway associates with pyroptosis and inflammation in patients with endometriosis
Mingli An, Xinping Fu, Xin Meng, et al.
Journal of Reproductive Immunology (2024) Vol. 162, pp. 104213-104213
Open Access | Times Cited: 8
Neutrophil extracellular traps activate hepatic stellate cells and monocytes via NLRP3 sensing in alcohol-induced acceleration of MASH fibrosis
Mrigya Babuta, Caroline Morel, Marcelle de Carvalho Ribeiro, et al.
Gut (2024) Vol. 73, Iss. 11, pp. 1854-1869
Open Access | Times Cited: 8
Mortality outcomes in individuals with MASLD versus MASLD and increased alcohol intake
Majd B. Aboona, Pojsakorn Danpanichkul, Vincent Chen, et al.
Journal of Gastroenterology and Hepatology (2024) Vol. 39, Iss. 11, pp. 2456-2463
Closed Access | Times Cited: 8
Unveiling the flames: macrophage pyroptosis and its crucial role in liver diseases
Linghong Ni, Dandan Chen, Yanping Zhao, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 7
Therapeutic Effects of Berberine on Liver Fibrosis are associated With Lipid Metabolism and Intestinal Flora
Xianzhi Liu, Lifu Wang, Siwei Tan, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 32
Sodium Alginate Prevents Non-Alcoholic Fatty Liver Disease by Modulating the Gut–Liver Axis in High-Fat Diet-Fed Rats
Hui Zhao, Xiang Gao, Zhizuo Liu, et al.
Nutrients (2022) Vol. 14, Iss. 22, pp. 4846-4846
Open Access | Times Cited: 31
NLRP3 inflammasome in hepatic diseases: A pharmacological target
Erika Ramos‐Tovar, Pablo Muriel
Biochemical Pharmacology (2023) Vol. 217, pp. 115861-115861
Closed Access | Times Cited: 20
Programmed cell death and lipid metabolism of macrophages in NAFLD
Zhun Xiao, Minghao Liu, Fangming Yang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 19
Page 1 - Next Page

Scroll to top